Gene · 9294
Papers2,171
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,171
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GCDCA promotes hepatocellular carcinoma progression through S1PR2/PI3K/AKT-mediated polarization of M2-type macrophages. | Front Immunol | 2026 | 41808818 | PubTator, text mining | PubMed |
| Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models. | Oncol Res | 2026 | 41799523 | PubTator, text mining | PubMed |
| Epstein-Barr virus-associated lymphoma: current understanding and treatment strategies. | Blood Res | 2026 | 41793645 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Efficacy and safety of Shexiang Tongxin pill for coronary slow flow in angina patients. | NPJ Cardiovasc Health | 2026 | 41775867 | PubTator, text mining | PubMed |
| Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities. | Pharmacol Rev | 2026 | 41759374 | PubTator, text mining | PubMed |
| Organoids Gone Viral: A Comprehensive Review on Human Organoid Models to Study Viral Pathogenesis. | Viruses | 2026 | 41754581 | PubTator, text mining | PubMed |
| From Exposure to Atherosclerosis: Mechanistic Insights into Phthalate-Driven Ischemic Heart Disease and Prevention Strategies. | Life (Basel) | 2026 | 41752962 | PubTator, text mining | PubMed |
| Clinical Efficacy of Acupuncture for Knee Osteoarthritis and Associated Changes in Serum Lipidomics: A Prospective Observational Cohort Study. | J Pain Res | 2026 | 41727563 | PubTator, text mining | PubMed |
| Metabolic plasticity of sphingolipids governs cancer cell fitness in acidic tumor ecosystems. | bioRxiv | 2026 | 41726913 | PubTator, text mining | PubMed |
| The Acid sphingomyelinase/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment Target. | Inflammation | 2026 | 41721077 | PubTator, text mining | PubMed |
| Synthetic strategies and therapeutic insights into FDA-approved indole-containing drugs. | J Enzyme Inhib Med Chem | 2026 | 41601150 | PubTator, text mining | PubMed |
| Bile Acids as Key Mediators of the Gut Microbiota-Immune Axis: Potential Biomarker and Therapeutic Perspectives. | Biofactors | 2026 | 41582717 | PubTator, text mining | PubMed |
| Taurocholic Acid Is Associated With Disturbed Functional Connectivity in the Hippocampus of Patients With Depression. | Adv Sci (Weinh) | 2026 | 41437183 | PubTator, text mining | PubMed |
| S1PR-Targeted PET Imaging: Advancing Insights into Neuroinflammatory and Immune-Related Pathologies. | Mol Pharm | 2026 | 41397090 | PubTator, text mining | PubMed |
| Serum-urine metabolic integration via UPLC-QTOF/MS uncovers shared pathway biomarkers for cirrhosis diagnosis. | Front Med (Lausanne) | 2025 | 41737570 | PubTator, text mining | PubMed |
| S1PR2 Signaling in the Lung: Understanding Its Role in Health and Disease. | Cells | 2025 | 41511294 | PubTator, text mining | PubMed |
| Multimodal analysis defines GNG4 as a distinguishing feature of germinal center-positioned CD4 T follicular helper cells in humans. | bioRxiv | 2025 | 41427421 | PubTator, text mining | PubMed |
| Glycochenodeoxycholic acid promotes hepatocarcinogenesis by inducing hepatic progenitor cell differentiation into cancer-associated fibroblasts via sphingosine-1-phosphate receptor 2 signalling. | Biomark Res | 2025 | 41408647 | PubTator, text mining | PubMed |
| Selective Activation of GPCRs: Molecular Dynamics Shows Siponimod Binds but Fails To Activate S1PR2, Unlike S1PR1. | J Chem Inf Model | 2025 | 41342738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9294/papers?page=2